Position in JNJ
as of Jun 30, 2026
· filed Jul 7, 2026
Position Value
$8,217,453
+$245,532 QoQ
Shares Held
32,356
-0.8% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.18%
of 13F equity value
Holder Rank
#1,224
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 97%
Shared 0%
None 3%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026JGP Wealth Management, LLC holds $32,516,305 across 7 Drug Manufacturers - General names. JNJ ranks #2 (25.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AMGN |
Amgen Inc
|
43,268 | $15,668,208 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
32,356 | $8,217,453 | |
| 3 | ABBV |
AbbVie Inc.
|
17,144 | $4,314,116 | |
| 4 | LLY |
ELI LILLY & Co
|
1,736 | $2,082,210 | |
| 5 | MRK |
Merck & Co., Inc.
|
12,367 | $1,589,159 | |
| 6 | NVS |
Novartis AG
|
2,511 | $393,523 | |
| 7 | PFE |
Pfizer Inc
|
10,450 | $251,636 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,217,453 | 32,356 | Shares | Sole | 2026-07-07 | |
| 2026-03-31 | $7,971,921 | 32,613 | Shares | Sole | 2026-04-08 | |
| 2025-12-31 | $8,820,002 | 42,619 | Shares | Sole | 2026-01-12 | |
| 2025-09-30 | $7,793,202 | 42,030 | Shares | Sole | 2025-10-15 | |
| 2025-06-30 | $6,440,703 | 42,165 | Shares | Sole | 2025-07-28 | |
| 2025-03-31 | $6,873,404 | 41,446 | Shares | Sole | 2025-04-09 | |
| 2024-12-31 | $9,867,422 | 68,230 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $12,766,762 | 78,778 | Shares | Sole | 2024-10-09 | |
| 2024-06-30 | $12,851,556 | 87,928 | Shares | Sole | 2024-07-12 | |
| 2024-03-31 | $13,819,478 | 87,360 | Shares | Sole | 2024-04-24 | |
| 2023-12-31 | $14,838,575 | 94,670 | Shares | Sole | 2024-01-10 | |
| 2023-09-30 | $14,034,476 | 90,109 | Shares | Sole | 2023-10-19 | |
| 2023-06-30 | $14,573,042 | 88,044 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $13,092,540 | 84,468 | Shares | Sole | 2023-04-14 | |
| 2022-12-31 | $13,732,947 | 77,741 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $11,121,712 | 68,081 | Shares | Sole | 2022-10-14 | |
| 2022-06-30 | $11,554,125 | 65,090 | Shares | Sole | 2022-07-19 | |
| 2022-03-31 | $11,246,484 | 63,457 | Shares | Sole | 2022-04-20 | |
| 2021-12-31 | $10,200,733 | 59,629 | Shares | Sole | 2022-01-18 | |
| 2021-09-30 | $9,186,604 | 56,883 | Shares | Sole | 2021-10-13 | |
| 2021-06-30 | $9,246,361 | 56,127 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $8,291,621 | 50,451 | Shares | Sole | 2021-04-28 | |
| 2020-12-31 | $7,801,956 | 49,574 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $6,956,269 | 46,724 | Shares | Sole | 2020-10-13 | |
| 2020-06-30 | $6,321,740 | 44,953 | Shares | Sole | 2020-07-13 | |
| 2020-03-31 | $5,541,422 | 42,259 | Shares | Sole | 2020-04-14 | |
| No filing history on record for this holder in this stock. | ||||||